Eli Lilly will cut prices for some older insulins later this year and immediately give more patients access to a cap on the costs they pay to fill prescriptions. The moves announced Wednesday promise ...

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...

INDIANAPOLIS — Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay to fill prescriptions. The moves announced Wednesday promise ...

Eli Lilly will cut the price of its most commonly prescribed insulin products by 70% and expand a program that caps patient costs at $35 per month, the company said on Wednesday. "While the current ...

Eli Lilly CEO David Ricks told CNBC June 29 that the drugmaker will look for new ways to cut insulin prices in the face of competition from Walmart, which launched its own private label insulin at ...

With detailed readouts from a suite of late-stage trials now on tap, Eli Lilly is heading to regulators in pursuit of a green light for its once-a-week insulin asset efsitora alfa. Lilly on Sunday ...

Ricks was the only executive who outright agreed to Sanders' demand – at least for Eli Lilly's existing insulin products. "We'll leave our prices as they are for the insulins on the market today," ...

Eli Lilly is looking to approach regulators for approval of its once-weekly insulin for type 2 diabetes (T2D) after it proved non-inferior to daily dosing. The QWINT-1 (NCT05662332), QWINT-3 ...